BioNxt Solutions Inc.
BNXTF
$0.3747
$0.0257.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.67% | 59.43% | -5.51% | 66.58% | 28.32% |
| Total Depreciation and Amortization | -53.19% | -59.17% | -53.01% | -0.63% | 46.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.48% | -66.85% | 47.39% | -92.07% | -57.44% |
| Change in Net Operating Assets | 1,496.24% | -157.01% | 205.24% | 168.36% | 91.89% |
| Cash from Operations | 78.97% | 40.55% | 37.50% | 8.27% | 40.35% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 147.79% | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 99.71% | 15.60% |
| Issuance of Common Stock | -100.00% | -- | -78.60% | -- | -59.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | 74.18% | -- | 59.51% |
| Cash from Financing | -100.00% | 502.81% | -78.79% | 228.94% | -60.76% |
| Foreign Exchange rate Adjustments | 158.33% | 111.11% | -94.12% | -47.06% | -500.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -189.57% | 114.42% | -116.05% | 88.55% | -84.07% |
